BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8816660)

  • 1. Operative treatment of intramedullary hematoma associated with congenital deficiency of alpha 2-plasmin inhibitor, A report of three cases.
    Miyauchi Y; Mii Y; Aoki M; Tamai S; Takahashi Y; Yoshioka A
    J Bone Joint Surg Am; 1996 Sep; 78(9):1409-14. PubMed ID: 8816660
    [No Abstract]   [Full Text] [Related]  

  • 2. Intramedullary multiple hematomas in siblings with congenital alpha-2-plasmin inhibitor deficiency: orthopedic surgery with protection by tranexamic acid.
    Takahashi Y; Tanaka T; Nakajima N; Yoshioka A; Fukui H; Miyauchi Y; Mii Y; Tamai S
    Haemostasis; 1991; 21(5):321-7. PubMed ID: 1806461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of Japanese researchers to progress in the field of hematology in the last 100 years: Congenital deficiency of alpha2-plasmin inhibitor].
    Kamiya T; Aoki N; Saito H; Kohakura S; Koie K
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2062-5. PubMed ID: 12187678
    [No Abstract]   [Full Text] [Related]  

  • 4. Dialysis for a patient who had congenital deficiency of alpha 2-plasmin inhibitor.
    Tatematsu M; Higa A; Sunagawa H; Ikehara O; Shiohira Y
    Clin Nephrol; 1998 May; 49(5):335-6. PubMed ID: 9617504
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital alpha(2)-plasmin inhibitor deficiencies: a review.
    Favier R; Aoki N; de Moerloose P
    Br J Haematol; 2001 Jul; 114(1):4-10. PubMed ID: 11472338
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of intramedullary haematoma associated with congenital alpha2-plasmin inhibitor deficiency.
    Devaussuzenet VM; Ducou-le-Pointe HA; Doco AM; Mary PM; Montagne JR; Favier R
    Pediatr Radiol; 1998 Dec; 28(12):978-80. PubMed ID: 9880645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
    Colucci G; Alberio L; Jahns M; Keller P; Steiner S; Rüsges-Wolter I; Lämmle B
    Thromb Haemost; 2009 Dec; 102(6):1285-7. PubMed ID: 19967165
    [No Abstract]   [Full Text] [Related]  

  • 8. Dental extraction in a hemophilia patient without factor replacement therapy: a case report.
    Bajkin BV; Rajic NV; Vujkov SB
    J Oral Maxillofac Surg; 2012 Oct; 70(10):2276-7. PubMed ID: 22494511
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic alternatives to transfusion.
    Ness PM
    Vox Sang; 2002 Aug; 83 Suppl 1():3-6. PubMed ID: 12617091
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty.
    Sabatini L; Atzori F; Revello S; Scotti L; Debiasi F; Massè A
    Arch Orthop Trauma Surg; 2014 Nov; 134(11):1609-14. PubMed ID: 25179896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local and systemic hemostasis in surgery].
    Bechstein WO; Strey C
    Chirurg; 2007 Feb; 78(2):95-6, 98-100. PubMed ID: 17237955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
    Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
    Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A splicing donor site point mutation in intron 6 of the plasmin inhibitor (alpha2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency.
    Hanss MM; Farcis M; Ffrench PO; de Mazancourt P; Dechavanne M
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):107-11. PubMed ID: 12544738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents?
    Hardy JF; Bélisle S
    Can J Anaesth; 1997 Sep; 44(9):913-7. PubMed ID: 9305552
    [No Abstract]   [Full Text] [Related]  

  • 16. May restricted specificity of commercially available plasmin inhibitor activity assays affect correct diagnosis of antiplasmin deficiency?
    Pozzi L; Della Valle P; D'Angelo A
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):52-53. PubMed ID: 30672814
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of antifibrinolytic agents used in hemostatic fibrin sealants.
    Busuttil RW
    J Am Coll Surg; 2003 Dec; 197(6):1021-8. PubMed ID: 14644291
    [No Abstract]   [Full Text] [Related]  

  • 18. Congenital deficiency of alpha 2-plasmin inhibitor in three sisters.
    Yoshioka A; Kamitsuji H; Takase T; Iida Y; Tsukada S; Mikami S; Fukui H
    Haemostasis; 1982; 11(3):176-84. PubMed ID: 7095605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital deficiency of the fibrinolysis inhibitor alpha 2-antiplasmin as a cause of hemorrhagic diathesis].
    Leebeek FW; Knot EA; Kluft C
    Ned Tijdschr Geneeskd; 1988 Jan; 132(4):167-70. PubMed ID: 3277073
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
    Dewerchin M; Collen D; Lijnen HR
    Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.